Judge Lamberth’s court injunction on federal funding of embryonic stem cell research was temporarily lifted September 9, but much remains in question. In today’s edition of Nature (September 23rd), a legal panel examines the case. Panelist Patrick Taylor, former Chief Counsel for Research Affairs at Children’s, weighs in on the ambiguities of the Dickey-Wicker amendment, what kind of legislative action is needed, and the prospects for NIH funding of research on the embryonic stem cell lines created under Obama, the so-called Bush Lines, and new lines waiting to be created.
Related Posts :
- Why blood stem cells are in our bones: Evolutionary observation may inform better bone marrow transplants
- Poised pluripotency: A glimpse of the early embryo just as it’s implanting
- Probing the brain’s earliest development, with a detour into rare childhood cancers
- Intestine chip models gut function, in disease and in health
- More surprises about blood development — and a possible lead for making lymphocytes